Home›Stock Screener›Gennex Laboratories›Quarterly Results

Gennex Laboratories Quarterly Results

Latest Quarter Net Profit
₹5 Cr
QSept 2026
Quarterly Results

Gennex Laboratories quarterly results. In Sept 2026, Gennex Laboratories (GENNEX) reported revenue ₹44 Cr and net profit ₹5 Cr — revenue +18.9% YoY. View GENNEX 52-week chart for the annual high/low range and current price position.

GENNEX Quarterly Results — Revenue, Profit & EPS Highlights

Gennex Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Gennex Laboratories screener.

  • Revenue of ₹44 Cr in Sept 2026 (-29.0% vs Mar 2026, +18.9% vs Sept 2025)
  • Net Profit of ₹5 Cr in Sept 2026 (+0.0% vs Mar 2026, -16.7% vs Sept 2025)
  • EBITDA of ₹7 Cr in Sept 2026 (+0.0% vs Mar 2026)
  • Operating Margin of 13.0% in Sept 2026 (+4.0pp vs Mar 2026)
  • Earnings Per Share of ₹0.17 in Sept 2026 (+6.3% vs Mar 2026)

Gennex Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GENNEX quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 44 62 42 37 44 -29.0% 18.9%
Net Profit (₹ Cr) 5 5 5 6 3 - -
EBITDA (₹ Cr) 7 7 6 6 6 - -
EPS (₹) 0.17 0.16 0.19 0.21 0.14 - -
Operating Margin (%) 13.0% 9.0% 11.0% 15.0% 5.0% - -

GENNEX Share Price Trend — 1-Year Movement Across Quarterly Results

Gennex Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore GENNEX share price history to track price trends across different timeframes.

Profitability Ratios

Profit Margin 11.4%
EBITDA Margin 15.9%
Operating Margin 13.0%
ROE (Annual) 8.6%

Balance Sheet Highlights

Total Assets ₹349 Cr
Total Equity ₹233 Cr
Current Assets ₹ Cr
Current Liabilities ₹43 Cr

Cash Flow Analysis

Operating Cash Flow ₹-64 Cr
Investing Cash Flow ₹-5 Cr
Financing Cash Flow ₹65 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹8.87
Exchange BSE
Last Updated Nov 20, 2026

GENNEX vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Gennex Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1884.9 16,617 1,995 +10.6% - 12.0% 227.1
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11180.5 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4689.5 4,111 364 +27.7% +42.2% 8.9% 407.4
Apollo Hospitals
Sept 2026
₹132,281.88 Cr 9200.0 7,673 660 +15.2% - 8.6% 209.9
Laurus Labs
Sept 2026
₹125,946.78 Cr 2294.6 2,219 436 +21.7% - 19.6% 280.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores